Regulatory Requirements and Considerations for Preliminary Clinical Trials of Vaccine in Medical Institutions

Chen Yifei, Xu Ying, Sun Bo, Li Gang

Chinese Pharmaceutical Affairs ›› 2022, Vol. 36 ›› Issue (1) : 10-15.

Chinese Pharmaceutical Affairs ›› 2022, Vol. 36 ›› Issue (1) : 10-15. DOI: 10.16153/j.1002-7777.2022.01.002

Regulatory Requirements and Considerations for Preliminary Clinical Trials of Vaccine in Medical Institutions

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 36(1): 10-15 https://doi.org/10.16153/j.1002-7777.2022.01.002

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉